Stocks in Focus on October 9: Vedanta, Dr Reddy’s, Lakshmi Vilas Bank to CONCOR; here are the 5 Newsmakers of the Day

Stocks in Focus on October 9: Equity benchmarks extended gains for the sixth session in a row on Thursday, October 8, 2020, amid positive global cues. The surge was led by gains in banks and IT shares. The S&P BSE Sensex jumped 303.72 points, or 0.76 per cent, to 40,182.67. The Nifty 50 index rallied 95.75 points, or 9.82 per cent, to 11,834.60. But certain stocks came in news after the market was closed. These stocks can impact the indices when it reopens on Friday, October 9, 2020. List of such five stocks:  

Triggers: Certain events, like Results to be announced today and RBI Policy, can create positive/negative reactions in the share market when it opens today. Find them in detail:

Results Today: Steel Strip Wheels, RCF (Q4FY20). 
RBI MPC: RBI will announce the credit policy at 10 am, today.

Vedanta (Delisting Update): Bids for 73.76 crores shares of Vedanta have been tendered by the public shareholders in the buyback offer so far. The company needs bids for 134.5 crore shares for a successful delisting. The company needs bids for 60.74 crore shares today for a successful delisting. Today is the final day of the reverse book building process in which public shareholders can tender their shares. Besides, Vedanta in a regulatory filing has said that certain brokers registered with the BSE are not allowing public shareholders to place their bids above the floor price. Listing regulations state that public shareholders may submit their bid at any price at or above the floor price.

Dr. Reddy's Laboratories: DGCI, India’s apex drug regulator, has rejected pharmaceutical major Dr Reddy’s Laboratories to directly conduct the phase-3 trial for Russian Covid-19 vaccine Sputnik V directly in India saying that the sample size for early human trials for the vaccine was “small”. The regulator has asked the pharma company to submit a revised proposal for phase 2 trials instead of phase-3 in the country. Dr Reddy’s has asked DGCI to approve phase-3 trial, which usually requires testing over 1,000 participants. DGCI has asked for a small sample size. 

Lakshmi Vilas Bank: The bank has said it has received an indicative non-binding offer from Clix Group. The company has not provided any further details of the offer at the exchanges. There are reports that the Clix Group has plans to invest around Rs 1,500-1,700 crore in Lakshmi Vilas Bank. After the investment, Clix Group's stake in the bank will be more than 74%. The Group has sought exemption from the 3-year lock-in period rule.

CONCOR (Q2 Volume update): Container Corporation of India Ltd. (CONCOR) on Thursday provided its volume update for the second quarter of the financial year 2020-21 (Q2FY21) and said its physical volume declines by 8.61% in the period. Total volume declined from 9.69 lakh Twenty-Foot Equivalent Units (TEUs) in the quarter ended September 30, 2020, to 8.85 lakh TEUs reported in the quarter ended September 30, 2019.